Sofinnova Venture Partners IX, L.P. - 19 Dec 2025 SCHEDULE 13D/A Report for NextCure, Inc. Common Stock, $0.001 par value (NXTC)

Filing Manager
Sofinnova Venture Partners IX, L.P.
Reporting Manager
Sofinnova Venture Partners IX, L.P. ("SVP IX")
Security
NextCure, Inc. Common Stock, $0.001 par value
Symbol
NXTC
Shares outstanding
3,135,972 shares
Disclosed Ownership
222,654 shares
Ownership
7.1%
Form type
SCHEDULE 13D/A
Filing time
05 Mar 2026, 06:06:07 UTC
Date of event
19 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Venture Partners IX, L.P. ("SVP IX") 7.1% 222,654 222,654 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact 0001612133
Sofinnova Management IX, L.L.C. ("SM IX") 7.1% 222,654 222,654 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Dr. James I. Healy ("Healy") 7.1% 222,654 222,654 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact